Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Berlex now marketing Levulan Kerastick photodynamic therapy in U.S.

Dec. 13, 2000

FDA approves Protopic for the treatment of eczema

Dec. 11, 2000

NicOx's HCT-1026 shows promise for treatment of skin inflammation

Nov. 29, 2000

Dusa moves Levulan into phase I/II for the treatment of acne

Nov. 29, 2000

Phytopharm begins phase II trial of P-45 for alopecia areata

Nov. 28, 2000

Angiotech begins phase II trial with micellar paclitaxel for psoriasis

Nov. 27, 2000

Licensing opportunity from NIH: smad3 protein inhibition to enhance wound healing

Nov. 20, 2000

Steroid-free eczema treatment recommended for FDA approval

Nov. 17, 2000

Cellegy seeks approval of Rectogesic in New Zealand

Nov. 15, 2000

MBI-594AN advances to phase II for treatment of acne

Nov. 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...